SCHEMBL5216698

SCHEMBL5216698

CC(=O)NC[C@H]1CN(c2cc(F)c(C3CC[S+]([O-])CC3)c(F)c2)C(=O)O1

nearest known ligand 0.58

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.58
MAOB P27338 3/20 0.58
PTGS1 P23219 2/20 0.58
SDHA P31040 2/20 0.58
LMNA P02545 1/20 0.58
CALML3 P27482 1/20 0.58
F10 P00742 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164776 0.88 MAOA (0.60) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6164308 0.88 MAOA (0.60) MAOAMAOBPTGS1SDHALMNA
SCHEMBL1176221 0.88 MAOA (0.60) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6164310 0.88 MAOA (0.60) MAOAMAOBPTGS1SDHALMNA
SCHEMBL22689508 0.87 MAOA (0.54) MAOAMAOBPTGS1SDHALMNA
SCHEMBL22698339 0.87 MAOA (0.54) MAOAMAOBPTGS1SDHALMNA
SCHEMBL4883459 0.86 MAOA (0.57) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6402361 0.86 MAOA (0.60) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6382854 0.86 MAOA (0.69) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6402357 0.86 MAOA (0.60) MAOAMAOBPTGS1SDHALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467992-B1 ANTIMICROBIAL DIHYDROTHIAZINE AND DIHYDROTHIOPYRAN OXAZOLIDINONES PHARMACIA & UPJOHN CO LLC (US) 2007-08-08 EP disclosed
US-7101874-B2 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones PHARMACIA AND UPJOHN COMPANY (US) 2006-09-05 US disclosed
US-20050143376-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones GORDEEV MIKHAIL F (US) 2005-06-30 US disclosed
US-6884813-B2 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones PHARMACIA & UPJOHN COMPANY (US) 2005-04-26 US disclosed
US-20030232812-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones PHARMACIA & UPJOHN COMPANY 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143376-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones DHX35, DHX15, OXA1L MAOA 3852/4885MAOB 3530/4885PTGS1 2901/4885
US-20030232812-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones DHX35, ZYX, DHX15 MAOA 3803/4885MAOB 3725/4885PTGS1 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.